Companies Seek Vaccine Approval as COVID-19 Cases Rise
On Tuesday, November 30, biopharmaceutical firms BioNTech and Moderna applied for approval of their respective COVID-19 vaccines in the European Union (EU), The Wall Street Journal reports. National Geographic says the EU is expected to conclude Pfizer’s assessment by December 29 and Moderna’s by January 12. Both Moderna and Pfizer Inc. also applied for emergency usage of their vaccines in the United States at the end of November, though it is unclear when a decision will be made.
Read More